Funding
We gratefully acknowledge current and previous funding.
Current support
- UMass President's Office, OTCV Technology Development Award: A Smartphone-controlled Battery-powered Portable Medical Device for Intraoral Photodynamic Therapy.
- NIH/NCI U54CA156734: Development of synergistic light-activated and anti-microRNA combination therapies for pancreatic ductal adenocarcinoma.
- NSF 1843101, STTR Phase 1: Flexible Quantum Dot Light Emitting Devices for Photodynamic Therapy and Photobiomodulation.
- NIH/NCI UH3CA189901: Low-cost Enabling Technology for Image-Guided Photodynamic Therapy of Oral Cancer.
Previous support
- NIH/NCI K99/R00 CA155045: "Mechanism-based therapies for pancreatic cancer informed by stromal microrheology."
- NIH/NCI UH2CA189901: "Low-cost enabling technology for image-guided photodynamic therapy of oral cancer."
- UMass Boston, Joseph P. Healey Grant: High-Throughput Microfluidics-based Characterization of Cells to Inform Cancer Therapeutics.
- NIH/NCI U54CA156734: Development of novel anti-microRNA and photomedicine combination therapies for pancreatic cancer using patient-derived organoid co-culture models.
- UMass Boston, Joseph P. Healey Grant: Stochastic Modeling of Phenotypic Switching and Chemoresistance in Cancer Cell Populations.
